Above the 40 (January 22, 2019) – Overbought Conditions Abruptly End In A Flurry of Tests of Support

AT40 = 66.4% of stocks are trading above their respective 40-day moving averages (DMAs) (ended 1-day overperiod)AT200 = 24.6% of stocks are trading above their respective 200DMAsVIX = 20.8Short-term Trading Call: neutral Commentary Days like these remind me of the importance of technicals. Just one trading day after surging into overbought trading territory, the stock … Read more

Above the 40 (December 14, 2018) – A Bear-Burdened Stock Market Dropped to Oversold and Passed A Trade-Positive Tweet

AT40 = 19.7% of stocks are trading above their respective 40-day moving averages (DMAs) (1st day oversold)AT200 = 20.7% of stocks are trading above their respective 200DMAs (34-month low)VIX = 21.6Short-term Trading Call: cautiously bullish CommentaryThe stock market is oversold again as a bearish divergence to start the week came to its “logical conclusion.” AT40 (T2108), … Read more

A Low Risk Way to Play Cramer’s Call for A Bottom In General Electric

General Electric (GE) has become THE disaster and rescue story in the U.S. stock market this year. Since it’s near-death experience in the financial crisis, GE ground out a slow but steady recovery before peaking in the summer of 2016 in the middle of a head and shoulders topping formation. That top fell well short … Read more

Above the 40 (June 22, 2018) – Stock Market Bears Increase the Pressure

AT40 = 63.1% ƒof stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 54.7% of stocks are trading above their respective 200DMAs (a 4-month high) VIX = 13.8 Short-term Trading Call: bearish Commentary In my last Above the 40 post, I described how growing global trade wars are creating widening divergences in … Read more

Above the 40 (June 20, 2018) – A Stock Market Divergence Made for Bears, Bulls, and Volatile Narratives

AT40 = 65.8% of stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 55.5% of stocks are trading above their respective 200DMAs (a 4-month high) VIX = 12.8 Short-term Trading Call: bearish Commentary The stock market is oozing with divergences as a result of global trade wars, especially the escalating spat between … Read more

Above the 40 (June 6, 2018) – A Broadening Stock Rally Stretches Toward Important Threshold

AT40 = 68.3% of stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 56.3% of stocks are trading above their respective 200DMAs (a 4-month high) VIX = 11.6 Short-term Trading Call: neutral Commentary It is tough avoiding a flip on my short-term trading call to bullish, but I am sticking by my … Read more

Above the 40 (June 1, 2018) – Uncomfortable Divergences Weigh On the Stock Market’s Manic Rally

AT40 = 62.5% of stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 52.7% of stocks are trading above their respective 200DMAs (a near 4-month high) VIX = 13.5 (down 12.8%) Short-term Trading Call: neutral Commentary A day like this past Friday makes me want to be bullish about the entire stock … Read more

A Cocoa Surprise: Prices Spring Back to Life

In commodities, the time to get bullish is usually when prices are pressuring the industry and sentiment is persistently and deeply negative. The time to get bearish is usually when prices are skyrocketing, industry participants are celebrating wondrous fortunes, and sentiment is as euphoric as can be. Since I am long-term bullish on cocoa, I … Read more

Trading An Iron Ore Top: Prices Stall Amid Record Chinese Imports and Inventories

Iron ore may have reached a new inflection point with a price rally coming to a halt in January and some related stocks consolidating near multi-year highs. When I last made an iron ore trade in September, 2017, I was responding to a surprise projection from the Reserve Bank of Australia (RBA) that suggested a … Read more

The Danger in DexCom…and the Opportunity

DexCom (DXCM) is a maker of continuous glucose monitoring (CGM) systems. Last week, the stock of the company cratered after Abbott Laboratories (ABT) received FDA approval of its competing FreeStyle Libre flash CGM. It is the first system that allows diabetics to check and monitor glucose levels without sticking themselves. In response to the news, … Read more